International Society of Chylomicrons in Disease

ZILVERSMIT ORATION:
Professor Ernst J. Schaefer, MD. Distinguished University Professor. Tufts University School of Medicine, Friedman School of Nutrition Science and policy.
Senior Scientist and Director, Lipid Metabolism Laboratory
Human Nutrition Research Center on Aging at Tufts University
Boston, MA 02111

Professor Børge G. Nordestgaard, MD, DMSc is Chief Physician at Copenhagen University Hospital and Professor at University of Copenhagen, Denmark.  Scientific education was with Steen Stender in Copenhagen, Donald Zilversmit in Ithaca, New York, and with Barry Lewis in London. Clinical training included hyperlipidemia, cardiology, and clinical biochemistry. Professor Nordestgaard is chairing the Copenhagen General Population Study (www.cgps.dk) and is also a steering committee member of the Copenhagen City Heart Study, the JUPITER trial, and the High Risk Plaque Initiative.

Dr. Spencer Proctor trained as a physiologist and cardiovascular scientist in both Australia and Canada. He was appointed to the Alberta Institute for Human Nutrition at the University of Alberta in 2004 and founded the Metabolic and Cardiovascular Diseases (MCVD) Laboratory. Dr. Proctor’s research program spans a unique continuum of expertise in the areas of nutrition, metabolism, physiology, behaviour, food health and chronic disease. 

Kathleen Botham graduated with a BSc(Hons) in Biochemistry from the University of Liverpool in 1969, and she obtained a PhD in Biochemistry from the same institution in 1972. After a period of three years in the United States working with Hector DeLuca on vitamin D metabolism, she returned to the UK to join the sterol metabolism group headed by Professor George Boyd at the University of Edinburgh. In 1986, she joined the Royal Veterinary College as a Lecturer, and was appointed to a Chair in Biochemistry in August 2007. Kathy was awarded a DSc by the University of Liverpool in 2002 for her contribution to research in the field of cholesterol and lipoprotein metabolism. Her current research centres on the role of fats and micronutrients from the diet in the development of atherosclerosis during their transport from the gut to the liver postprandially in triacylglycerol-rich lipoproteins.

Utilizing whole body, integrative, physiological studies in humans, Dr Lewis' main research interests are; determining the mechanism of intestinal and hepatic lipoprotein overproduction in insulin resistance and Type 2 diabetes. They are examining the regulation of intestinal and hepatic lipoprotein particle production by hormones and inflammatory factors in humans, particularly as they pertain to the insulin resistant condition. In addition, Dr Lewis has been investigating the effect of free fatty acids on pancreatic beta cell secretory function.